MarketPeel
Insider Trading Intelligence
EVP R&D, Chief Medical Officer
Mon, Feb 21, 2022
Feb 21
exercised or converted securities in ALKS
6,875 shares @ $0.00
Increased holdings by +41.40%
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.49%
1M-8.76%
3M
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback